Articles

Expert buy, hold and sell recommendations from our team of analysts.

Premium

“HOT” stock: Fisher & Paykel Healthcare (FPH)

Michael Gable, Managing Director of Fairmont Equities, says Fisher & Paykel Healthcare (FPH) has broken above a multi-year resistance line near $35, but after running hard it now looks overbought, and a pullback towards $37 would provide investors with a better entry point.

Maureen Jordan · October 29, 2026
Premium

Questions of the Week (29 October 2026)

How is the “trimmed mean inflation” rate calculated and why is it important to the RBA when thinking about the level of interest rates? Will I be able to buy shares in the Anthropic IPO? Do the brokers think there is any value with Wesfarmers? In relation to super, what is a ‘transfer balance cap’ and how can I find out how much I have available?

Paul Rickard · October 29, 2026
Premium

NextDC’s 40% plunge: is it a screaming buy?

NextDC shocked the market with a big guidance downgrade and its shares plunged more than 40% in a day. The brokers are still backing it, but is it really the “screaming buy” our webinar crowd thinks it is? I’ve run the ruler over what happened and what the brokers are saying.

Paul Rickard · October 26, 2026
Premium

“HOT” stock: Newmont Corporation (NEM)

For our “HOT” stock today, Raymond Chan, Private Client Adviser and Head of Asian Desk, Morgans, nominates gold giant Newmont Corporation (NEM), which has just delivered a solid third quarter result.

Maureen Jordan · October 26, 2026

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.